Access the full text.
Sign up today, get DeepDyve free for 14 days.
Keith Aaronson, J. Schwartz, Tze-Ming Chen, K. Wong, J. Goin, Donna Mancini (1996)
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.Circulation, 95 12
D. Altman, P. Royston (2000)
What do we mean by validating a prognostic model?Statistics in medicine, 19 4
K. Poppe, I. Squire, G. Whalley, L. Køber, F. McAlister, J. McMurray, S. Pocock, N. Earle, C. Berry, R. Doughty (2013)
Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta‐analysis reportEuropean Journal of Heart Failure, 15
J. Sterne, I. White, J. Carlin, Michael Spratt, P. Royston, M. Kenward, A. Wood, J. Carpenter (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsThe BMJ, 338
I. White, P. Royston, A. Wood (2011)
Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 30
S. Pocock, C. Ariti, J. McMurray, A. Maggioni, L. Køber, I. Squire, K. Swedberg, J. Dobson, K. Poppe, G. Whalley, R. Doughty (2013)
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.European heart journal, 34 19
D. Ruşinaru, C. Tribouilloy, C. Berry, A. Richards, G. Whalley, N. Earle, K. Poppe, M. Guazzi, S. Macin, M. Komajda, R. Doughty (2012)
Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta‐analysis †European Journal of Heart Failure, 14
J. Ludvigsson, P. Otterblad-Olausson, Birgitta Pettersson, A. Ekbom (2009)
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 24
K. Aaronson, J. Cowger (2012)
Heart failure prognostic models: why bother?Circulation. Heart failure, 5 1
Patrick Heagerty, Yingye Zheng (2005)
Survival Model Predictive Accuracy and ROC CurvesBiometrics, 61
P. Heagerty, T. Lumley, M. Pepe (2000)
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic MarkerBiometrics, 56
G. Whalley, R. Doughty (2011)
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.European heart journal, 33 14
D. Altman, Y. Vergouwe, P. Royston, K. Moons (2009)
Prognosis and prognostic research: validating a prognostic modelBMJ : British Medical Journal, 338
W. Levy, D. Mozaffarian, D. Linker, S. Sutradhar, S. Anker, A. Cropp, I. Anand, A. Maggioni, P. Burton, M. Sullivan, B. Pitt, P. Poole‐Wilson, D. Mann, M. Packer (2006)
The Seattle Heart Failure Model: Prediction of Survival in Heart FailureCirculation, 113
M. Martínez‐Sellés, R. Doughty, K. Poppe, G. Whalley, N. Earle, C. Tribouilloy, J. McMurray, K. Swedberg, L. Køber, C. Berry, I. Squire (2012)
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta‐analysis †European Journal of Heart Failure, 14
Maria Eklind-Cervenka, L. Benson, U. Dahlström, M. Edner, M. Rosenqvist, L. Lund (2011)
Association of candesartan vs losartan with all-cause mortality in patients with heart failure.JAMA, 305 2
L. Goldberg, M. Jessup (2007)
A time to be born and a time to die.Circulation, 116 4
Samer Nashef, François Roques, Linda Sharples, J. Nilsson, Christopher Smith, Antony Goldstone, Ulf Lockowandt (2012)
EuroSCORE II.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 41 4
K. Moons, A. Kengne, D. Grobbee, P. Royston, Y. Vergouwe, D. Altman, M. Woodward (2012)
Risk prediction models: II. External validation, model updating, and impact assessmentHeart, 98
C. O'connor, D. Whellan, D. Wojdyla, E. Leifer, R. Clare, Stephen Ellis, Lawrence Fine, J. Fleg, F. Zannad, S. Keteyian, D. Kitzman, W. Kraus, D. Rendall, I. Piña, L. Cooper, M. Fiuzat, Kerry Lee (2012)
Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction: The HF-ACTION Predictive Risk Score ModelCirculation: Heart Failure, 5
R. Little, R. D'Agostino, Michael Cohen, K. Dickersin, S. Emerson, J. Farrar, C. Frangakis, J. Hogan, G. Molenberghs, S. Murphy, J. Neaton, A. Rotnitzky, D. Scharfstein, W. Shih, J. Siegel, H. Stern (2012)
The prevention and treatment of missing data in clinical trials.The New England journal of medicine, 367 14
L. Gula, G. Klein, A. Hellkamp, D. Massel, A. Krahn, A. Skanes, R. Yee, Jill Anderson, G. Johnson, J. Poole, D. Mark, Kerry Lee, G. Bardy (2008)
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).American heart journal, 156 6
Yulei He (2010)
Missing data analysis using multiple imputation: getting to the heart of the matter.Circulation. Cardiovascular quality and outcomes, 3 1
Åsa Jonsson, M. Edner, U. Alehagen, U. Dahlström (2010)
Heart failure registry: a valuable tool for improving the management of patients with heart failureEuropean Journal of Heart Failure, 12
I. White, P. Royston (2009)
Imputing missing covariate values for the Cox modelStatistics in Medicine, 28
J. Somaratne, C. Berry, J. McMurray, K. Poppe, R. Doughty, G. Whalley (2009)
The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature‐based meta‐analysisEuropean Journal of Heart Failure, 11
Aims The aim of this study was to evaluate the performance of a recently developed risk score for mortality in heart failure by external validation in a national heart failure registry. Methods and results From 13 routinely available patient characteristics, the Meta‐analysis Global Group in Chronic Heart Failure (MAGGIC) constructed a risk score for prediction of mortality in heart failure. We included 51 043 patients from the national Swedish Heart Failure Registry and calculated the MAGGIC risk score for each patient. The outcome measure was 3‐year mortality. The predicted probability of death obtained from the calculated risk score was compared with the observed 3‐year mortality, and model discrimination and calibration were assessed by formal tests and graphical means. The overall 3‐year mortality in the study population was 39.4% and the MAGGIC project heart failure risk score predicted mortality was 36.4% (observed to expected ratio: 1.08). Discrimination was excellent overall (C index = 0.741). The difference between the model‐predicted and the observed 3‐year mortality in the six risk groups varied between 5% and −12%. Calibration plots demonstrated slight overprediction for the lowest risk patients, and underprediction in high risk patients. Conclusion The MAGGIC project heart failure risk score demonstrated an excellent ability to categorize patients in separate risk strata. Although the predicted 3‐year mortality risk was higher in low risk groups and lower in high risk groups compared with the observed 3‐year mortality in the Swedish Heart Failure Registry, the MAGGIC project heart failure risk score performed well in a large nationwide contemporary external validation cohort.
European Journal of Heart Failure – Wiley
Published: Feb 1, 2014
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.